All treatments
Treatment
Riximyo 500 mg concentrate for solution for infusion clinical trials
2 indexed studies · 0 currently recruiting
- AuthorisedTherapeutic exploratory (Phase II)
A phase II efficacy and safety study of cell-free circulating tumor DNA-guided commencement of second-line treatment in patients with DLBCL/HGBCL relapse
This study looks at new ways to decide when to start a second treatment for certain types of lymphoma, using a blood test. It aims to see if this approach is safe and effective in helping patients.
For: Diffuse large B-cell lymphomas (DLBCL · Diffuse large B-cell lymphoma) and aggressive B-cell lymphomas (HGBCL · High-grade B-cell lymphoma) originate from mature B-cells at various stages of terminal differentiationPoland - AuthorisedTherapeutic use (Phase IV)
A Randomized Trial of the I-BFM-SG for the Management of Childhood non-mature-B Acute Lymphoblastic Leukemia
This study is looking at new treatments for a type of childhood leukaemia. It aims to see if adding Riximyo to standard chemotherapy helps children live longer without the leukaemia coming back. The study also checks for side effects.
For: Childhood non-mature-B Acute Lymphoblastic LeukemiaGreece · Hungary · Croatia